Lung disease in mice with cystic fibrosis.Geraldine Kent, A. Keith Tanswell, Manuel Buchwald et al.|Journal of Clinical Investigation|1997Cited by 168
Characteristic Multiorgan Pathology of Cystic Fibrosis in a Long-Living Cystic Fibrosis Transmembrane Regulator Knockout Murine ModelPeter R. Durie, Cameron Ackerley, Geraldine Kent et al.|American Journal Of Pathology|2004Cited by 158
Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosisSatti Beharry, Peter R. Durie, Cameron Ackerley et al.|American Journal of Physiology-Gastrointestinal and Liver Physiology|2006Cited by 55
Expression of S100A8 correlates with inflammatory lung disease in congenic mice deficient of the cystic fibrosis transmembrane conductance regulatorSam Tirkos, Richard Rozmahel, Susan Newbigging et al.|Respiratory Research|2006Cited by 29
Assessment of the Efficacy of <i>In Vivo</i> CFTR Protein Replacement Therapy in CF MiceMohabir Ramjeesingh, Christine E. Bear, Ling‐Jun Huan et al.|Human Gene Therapy|1998Cited by 20